ProKidney Corp.
PROK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $376 | $249 | $958 | $716 |
| - Cash | $99 | $61 | $490 | $21 |
| + Debt | $3 | $4 | $2 | $1 |
| Enterprise Value | $280 | $193 | $470 | $697 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$158 | -$126 | -$144 | -$53 |
| % Margin | -208,542.1% | – | – | – |
| Net Income | -$61 | -$35 | -$108 | -$55 |
| % Margin | -80,507.9% | – | – | – |
| EPS Diluted | -0.62 | -0.57 | -1.76 | -1.73 |
| % Growth | -8.8% | 67.6% | -1.7% | – |
| Operating Cash Flow | -$126 | -$90 | -$77 | -$50 |
| Capital Expenditures | -$30 | -$34 | -$2 | -$5 |
| Free Cash Flow | -$156 | -$124 | -$79 | -$55 |